Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 222 clinical trials
featured
Lupus Research Study

This study is taking place at our Clearwater, FL office. It is for patients diagnosed with mild to moderate and moderate to severe lupus.

  • 25 views
  • 23 Nov, 2020
  • 1 location
featured
LILAC Study For Patients with Cutaneous and/or Systemic Lupus

LILAC Study For Patients with Cutaneous and/or Systemic Lupus

  • 960 views
  • 25 Mar, 2021
  • 2 locations
featured
  • 61 views
  • 23 Nov, 2020
  • 1 location
featured
Do you suffer from lupus?

Do you suffer from lupus? If so, you may qualify for a clinical trial at Wake Research testing an investigational medication designed for this condition.

lupus
  • 122 views
  • 18 May, 2020
  • 1 location
featured
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus (SLE)

A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus

  • 674 views
  • 08 Nov, 2020
  • 1 location
featured
A research study in subjects with Systemic Lupus Erythematosus to evaluate the clinical activity of an investigational medication.

A research study in subjects with Systemic Lupus Erythematosus to evaluate the clinical activity of an investigational medication.

  • 426 views
  • 23 Nov, 2020
  • 1 location
featured
LILAC Study For Patients with Cutaneous and/or Systemic Lupus

LILAC Study For Patients with Cutaneous and/or Systemic Lupus

  • 340 views
  • 25 Mar, 2021
  • 6 locations
featured
Rituximab plus Belimumab for Lupus Nephritis (CALIBRATE Study)

Rituximab plus Belimumab for Lupus Nephritis (CALIBRATE Study)

  • 926 views
  • 25 Mar, 2021
  • 12 locations
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of The Efficacy And Safety Of tofacitinib In Subjects With Active Ankylosing Spondylitis (AS).

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of The Efficacy And Safety Of tofacitinib In Subjects With Active Ankylosing Spondylitis (AS).  

  • 171 views
  • 23 Nov, 2020
  • 1 location
featured
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine

  • 346 views
  • 25 Mar, 2021
  • 1 location